X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
male (45) 45
adult (39) 39
female (37) 37
index medicus (23) 23
endocrinology & metabolism (22) 22
middle aged (22) 22
insulin resistance (15) 15
type 2 diabetes (14) 14
research (13) 13
aged (12) 12
diabetes (11) 11
glucose (11) 11
obesity (11) 11
risk factors (11) 11
blood glucose - metabolism (10) 10
diabetes mellitus, type 2 - drug therapy (10) 10
indians, north american (10) 10
adolescent (9) 9
health aspects (9) 9
multidisciplinary sciences (9) 9
obesity - metabolism (9) 9
blood glucose - analysis (8) 8
diabetes mellitus, type 2 - blood (8) 8
glucose tolerance test (8) 8
insulin (8) 8
insulin - blood (8) 8
lipids (8) 8
sensitivity (8) 8
diabetes mellitus, type 2 - metabolism (7) 7
glucose clamp technique (7) 7
animals (6) 6
article (6) 6
catecholamines (6) 6
complications and side effects (6) 6
insulin resistance - physiology (6) 6
nutrition & dietetics (6) 6
secretion (6) 6
triglycerides (6) 6
bed rest (5) 5
blood glucose - drug effects (5) 5
case-control studies (5) 5
cross-over studies (5) 5
dextrose (5) 5
exercise (5) 5
hyperglycemia (5) 5
hypoglycemic agents - therapeutic use (5) 5
iodide peroxidase - immunology (5) 5
mass spectrometry (5) 5
oxidative stress (5) 5
peripheral vascular disease (5) 5
physiological aspects (5) 5
pima-indians (5) 5
thyrotropin - blood (5) 5
triglycerides - blood (5) 5
young adult (5) 5
adolescents (4) 4
biomarkers - blood (4) 4
body mass index (4) 4
body weight - physiology (4) 4
cardiovascular diseases (4) 4
cardiovascular diseases - etiology (4) 4
care and treatment (4) 4
coronary-heart-disease (4) 4
cross-sectional studies (4) 4
diabetes mellitus (4) 4
disease (4) 4
environmental sciences (4) 4
fasting - blood (4) 4
follow-up (4) 4
glucagon-like peptide-1 (4) 4
glucose metabolism (4) 4
hypoglycemic agents - pharmacology (4) 4
impaired glucose-tolerance (4) 4
insulin - pharmacology (4) 4
lipoproteins (4) 4
longitudinal studies (4) 4
norepinephrine (4) 4
obesity - blood (4) 4
pcbs (4) 4
plasma (4) 4
postprandial period (4) 4
prognosis (4) 4
prolactin (4) 4
prolactin - blood (4) 4
proteins (4) 4
reference values (4) 4
resistance (4) 4
slovakia (4) 4
studies (4) 4
subcutaneous fat, abdominal - metabolism (4) 4
time factors (4) 4
tissue (4) 4
abridged index medicus (3) 3
adipocytes - metabolism (3) 3
adipogenesis (3) 3
adipose tissues (3) 3
apolipoproteins (3) 3
area under curve (3) 3
arizona (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes Care, ISSN 0149-5992, 03/2018, Volume 41, Issue 3, pp. 570 - 576
OBJECTIVE The goal of this study was to determine whether plasma levels of advanced glycation end products (AGE) and oxidation products (OP) predict the... 
MORTALITY | CARBOXYMETHYL-LYSINE | GLUCOSE CONTROL | SERUM-LEVELS | ENDOCRINOLOGY & METABOLISM | RENAL-FUNCTION | FOLLOW-UP | COMPLICATIONS | CORONARY-HEART-DISEASE | ENDPRODUCTS | PROTEINS | Methionine - blood | Cholesterol - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | 2-Aminoadipic Acid - blood | Case-Control Studies | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Deoxyglucose - analogs & derivatives | Methionine - analogs & derivatives | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Lysine - blood | Body Mass Index | Lysine - analogs & derivatives | Oxidation-Reduction | Risk Factors | Deoxyglucose - blood | Imidazoles - blood | Diabetes Mellitus, Type 2 - blood | Triglycerides - blood | Glycation End Products, Advanced - blood | Aged | Pyruvaldehyde - blood | Cohort Studies | Type 2 diabetes | Complications and side effects | Control | Cardiovascular diseases | Blood sugar | Risk factors | Cardiovascular system | Plasma | Advanced glycosylation end products | Kidneys | Diabetes mellitus | Methionine | Health risks | Cardiovascular disease | Glycosylation | Glucose | Patients | Minority & ethnic groups | Subgroups | Lysine | Hemoglobin | Oxidation | Plasma levels | Research design | Diabetes | Risk management | Pyruvaldehyde | Diabetes mellitus (non-insulin dependent) | Age | Cardiovascular and Metabolic Risk | 0102
Journal Article
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 05/2018, Volume 67, Issue Supplement 1, p. 1212
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 01/2018, Volume 20, Issue 1, pp. 69 - 76
AimsTo test whether liraglutide suppresses postprandial elevations in lipids and thus protects against high saturated fatty acid (SFA) diet-induced insulin... 
liraglutide | insulin resistance | randomised trial | EXENATIDE | IMPAIRED GLUCOSE-TOLERANCE | PEPTIDE-1 ANALOG | MICROVASCULAR RECRUITMENT | DIABETES-MELLITUS | SKELETAL-MUSCLE | HYPERGLYCEMIA | LIFE-STYLE | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | ONSET | Prediabetic State - metabolism | Hyperlipidemias - blood | Humans | Middle Aged | Diet, High-Fat - adverse effects | Male | Muscle, Skeletal - metabolism | Prediabetic State - drug therapy | Glucagon-Like Peptide-1 Receptor - metabolism | Liraglutide - pharmacology | Muscle, Skeletal - drug effects | Incretins - pharmacology | Postprandial Period | Adult | Female | Prediabetic State - etiology | Body Mass Index | Hypoglycemic Agents - therapeutic use | Hyperlipidemias - metabolism | Insulin Resistance | Prediabetic State - prevention & control | Microvessels - drug effects | Overweight - physiopathology | Hyperlipidemias - prevention & control | Hypoglycemic Agents - pharmacology | Cross-Over Studies | Subcutaneous Fat, Abdominal - drug effects | Hyperlipidemias - etiology | Liraglutide - therapeutic use | Subcutaneous Fat, Abdominal - blood supply | Aged | Incretins - therapeutic use | Vasodilation - drug effects | Glucagon-Like Peptide-1 Receptor - agonists | Cohort Studies | Proteins | Physiological aspects | Muscles | Insulin resistance | Triglycerides | Glucose | Fatty acids | Protein kinases | Dextrose | Phosphorylation | Adipose tissue | AMP | Arterioles | Lipids | Thioredoxin | AMP-activated protein kinase | Kinases | Insulin | Skeletal muscle | Vasodilation | Glucose tolerance | Glucose metabolism | Musculoskeletal system | Diet | Microvasculature | Regulatory proteins
Journal Article
Diabetes, ISSN 0012-1797, 02/2009, Volume 58, Issue 2, pp. 385 - 393
Journal Article
Atherosclerosis, ISSN 0021-9150, 2010, Volume 212, Issue 1, pp. 217 - 222
Abstract Objective Chronic exenatide treatment in type 2 diabetes is associated with improved glucose control and fasting lipid levels, as well as weight loss.... 
Cardiovascular | Remnant lipoproteins | High-fat meal | Apolipoprotein C-III | NEFA | Triglycerides | Apolipoprotein B-48 | Exenatide | MORTALITY | ATHEROGENESIS | MACROPHAGES | BLOOD-GLUCOSE | FATTY-ACIDS | METABOLISM | CIII | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | CARDIOVASCULAR RISK-FACTORS | APOLIPOPROTEIN-C-III | Dietary Fats - metabolism | Hyperlipidemias - blood | Cholesterol - blood | Humans | Middle Aged | Male | Insulin - blood | Apolipoprotein B-48 - blood | Glucose Intolerance - blood | Peptides - administration & dosage | Glucose Intolerance - drug therapy | Hypoglycemic Agents - administration & dosage | Time Factors | Injections, Subcutaneous | Lipids - blood | Dietary Fats - administration & dosage | Postprandial Period | Venoms - administration & dosage | Adult | Fatty Acids, Nonesterified - blood | Female | Arizona | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Apolipoprotein C-III - blood | Treatment Outcome | Biomarkers - blood | Lipoproteins - blood | Energy Intake | Hyperlipidemias - prevention & control | Blood Glucose - drug effects | Cross-Over Studies | Diabetes Mellitus, Type 2 - blood | Triglycerides - blood | Venoms - therapeutic use | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptides - therapeutic use | Type 2 diabetes | Atherosclerosis | Hypoglycemic agents | Glucose | Blood lipids | Apolipoproteins | Dextrose
Journal Article